InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,455.53
(
-0.32%
)
US TECH 100
19,233.20
(
-0.13%
)
Dow Jones
39,169.59
(
0.09%
)
Brent Oil
84.92
(
-0.11%
)
Bitcoin
63,471.39
(
-2.06%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

firehousestocks

Send PM Follow Ignore
Followers 23
Posts 866
Boards Moderated 0
Alias Born 06/05/2012

firehousestocks

Re: SABAI post# 83834

Tuesday, 07/09/2013 1:27:32 PM

Tuesday, July 09, 2013 1:27:32 PM

Post# of 158400
"We are pleased with the responses that we have provided to the FDA and look forward to initiating our clinical trials," stated David Koos, Chairman and CEO of Regen BioPharma. "Although it is possible that a second round of comments may be issued, we feel this process is extremely useful to creating a clinical trial that is optimized for safety and detection of efficacy."


Which means second round of questions may be needed. It does not mean they got another delay.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up